speb/financial-data huggingface dataset:
SYP.DE cash_flow (annual, 2024-10-31) — Other Non Cash Items: 205148000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Other Non Current Assets: 583700000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Other Non Current Liabilities: 46424000.00
SYP.DE income_statement (annual, 2024-10-31) — Other Non Operating Income Expenses: 64682000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Other Properties: 565917000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Other Receivables: 44166000.00
SYP.DE balance_sheet (quarterly, 2024-10-31) — Other Receivables: 44166000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Other Short Term Investments: 153869000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Payables: 354448000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Payables And Accrued Expenses: 1163592000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Preferred Stock: 0.00
SYP.DE income_statement (annual, 2024-10-31) — Pretax Income: 1513858000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Properties: 0.00
SYP.DE balance_sheet (quarterly, 2024-10-31) — Properties: 0.00
SYP.DE cash_flow (annual, 2024-10-31) — Provisionand Write Offof Assets: 19724000.00
SYP.DE cash_flow (annual, 2024-10-31) — Purchase Of Business: -156947000.00
SYP.DE cash_flow (quarterly, 2024-10-31) — Purchase Of Business: 0.00
SYP.DE cash_flow (annual, 2024-10-31) — Purchase Of Investment: -138114000.00
SYP.DE cash_flow (annual, 2024-10-31) — Purchase Of PPE: -139500000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Receivables: 934470000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Receivables Adjustments Allowances: -51008000.00
SYP.DE balance_sheet (quarterly, 2024-10-31) — Receivables Adjustments Allowances: -51008000.00
SYP.DE income_statement (annual, 2024-10-31) — Reconciled Cost Of Revenue: 966462000.00
SYP.DE income_statement (annual, 2024-10-31) — Reconciled Depreciation: 295065000.00
SYP.DE cash_flow (annual, 2024-10-31) — Repayment Of Debt: -2607000.00
SYP.DE cash_flow (annual, 2024-10-31) — Repurchase Of Capital Stock: 0.00
SYP.DE cash_flow (quarterly, 2024-10-31) — Repurchase Of Capital Stock: 0.00
SYP.DE income_statement (annual, 2024-10-31) — Research And Development: 2082360000.00
SYP.DE income_statement (annual, 2024-10-31) — Restructuring And Mergern Acquisition: 0.00
SYP.DE income_statement (quarterly, 2024-10-31) — Restructuring And Mergern Acquisition: 0.00
SYP.DE balance_sheet (annual, 2024-10-31) — Retained Earnings: 8984105000.00
SYP.DE cash_flow (annual, 2024-10-31) — Sale Of Business: 1446578000.00
SYP.DE cash_flow (annual, 2024-10-31) — Sale Of Investment: 194657000.00
SYP.DE cash_flow (annual, 2024-10-31) — Sale Of PPE: 16339000.00
SYP.DE income_statement (annual, 2024-10-31) — Selling And Marketing Expense: 859342000.00
SYP.DE income_statement (annual, 2024-10-31) — Selling General And Administration: 1427838000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Share Issued: 157260000.00
SYP.DE income_statement (annual, 2024-10-31) — Special Income Charges: 56983000.00
SYP.DE cash_flow (annual, 2024-10-31) — Stock Based Compensation: 692316000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Stockholders Equity: 8990702000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Tangible Book Value: 5346688000.00
SYP.DE income_statement (annual, 2024-10-31) — Tax Effect Of Unusual Items: 4176282.00
SYP.DE income_statement (annual, 2024-10-31) — Tax Provision: 99718000.00
SYP.DE income_statement (annual, 2024-10-31) — Tax Rate For Calcs: 0.07
SYP.DE balance_sheet (annual, 2024-10-31) — Total Assets: 13073561000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Total Capitalization: 9006303000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Total Debt: 684457000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Total Equity Gross Minority Interest: 9023206000.00
SYP.DE income_statement (annual, 2024-10-31) — Total Expenses: 4771725000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Total Liabilities Net Minority Interest: 4050355000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Total Non Current Assets: 6603895000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Total Non Current Liabilities Net Minority Interest: 1400235000.00
SYP.DE income_statement (annual, 2024-10-31) — Total Operating Income As Reported: 1355711000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Total Tax Payable: 147115000.00
SYP.DE income_statement (annual, 2024-10-31) — Total Unusual Items: 63277000.00
SYP.DE income_statement (annual, 2024-10-31) — Total Unusual Items Excluding Goodwill: 63277000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Treasury Shares Number: 3148000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Treasury Stock: 1025770000.00
SYP.DE balance_sheet (annual, 2024-10-31) — Working Capital: 3819546000.00
SYP.DE income_statement (quarterly, 2025-01-31) — Gain On Sale Of Business: 0.00
SYP.DE cash_flow (quarterly, 2025-01-31) — Net Other Investing Changes: -611000.00
SYP.DE cash_flow (quarterly, 2025-01-31) — Purchase Of Business: 0.00
SYP.DE income_statement (quarterly, 2025-01-31) — Restructuring And Mergern Acquisition: 0.00
SYP.DE income_statement (quarterly, 2025-04-30) — +Operating Expense: 909493000.00
SYP.DE income_statement (quarterly, 2025-04-30) — +Total Revenue: 1604266000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 84740000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 1002195000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 1219021000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Amortization: 3996000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Amortization Of Intangibles Income Statement: 3996000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Basic Average Shares: 154927000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Basic EPS: 2.23
SYP.DE cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 3657780000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -55588000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 691608000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Capital Stock: 1552000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 14119095000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 14263911000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: 10096449000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: 75977000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 275365000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Change In Inventory: 16086000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Change In Other Current Assets: 7436000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Change In Other Current Liabilities: -25515000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Change In Other Working Capital: -64300000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: 71122000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: -36905000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Change In Receivables: -105046000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Change In Working Capital: -137122000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: -105046000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Changes In Cash: 10447791000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Common Stock: 1552000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 9915718000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Common Stock Issuance: 103891000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 318347000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 699234000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Current Assets: 16879029000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 104170000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Current Debt: 22962000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 127132000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Current Deferred Liabilities: 1375398000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Current Deferred Revenue: 1375398000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 2406076000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Deferred Income Tax: -98095000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Deferred Tax: -98095000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 48904000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 3996000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 48904000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Depreciation And Amortization In Income Statement: 3996000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 156088000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Diluted EPS: 2.21
SYP.DE income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: 345332000.00
SYP.DE income_statement (quarterly, 2025-04-30) — EBIT: 490527000.00
SYP.DE income_statement (quarterly, 2025-04-30) — EBITDA: 539431000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Effect Of Exchange Rate Changes: 17862000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — End Cash Position: 14123433000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: 10096449000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 219777000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Gain On Sale Of Business: -2435000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Gain On Sale Of Ppe: 51385000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Gain On Sale Of Security: -178000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: -240136000.00
SYP.DE income_statement (quarterly, 2025-04-30) — General And Administrative Expense: 136497000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Goodwill: 3461272000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Goodwill And Other Intangible Assets: 3634666000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Gross PPE: 1157686000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Gross Profit: 1285919000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Income Tax Payable: 119572000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Interest Expense: 94336000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 94336000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Interest Income: 89890000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 89890000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Inventory: 395339000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Invested Capital: 19966361000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: 75977000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Issuance Of Capital Stock: 103891000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 587438000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Long Term Debt: 10027681000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 10615119000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Long Term Debt Payments: 0.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Minority Interest: -113000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Minority Interests: 222000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Net Business Purchase And Sale: 46274000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: 103891000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Net Income: 345332000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: 345332000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: 349010000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Net Income Discontinuous Operations: -3900000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: 345332000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: 349232000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: 345110000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: 345110000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Net Interest Income: -4446000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Net Investment Purchase And Sale: 11012000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Net Issuance Payments Of Debt: 10034464000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Net Long Term Debt Issuance: 10034464000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: -4446000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Net Other Financing Charges: -41906000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Net Other Investing Changes: 0.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Net PPE: 1157686000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: 18691000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 6281052000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Assets: 1898010000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Liabilities: 719984000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Revenue: 331133000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Taxes Assets: 1509159000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Normalized EBITDA: 490659000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Normalized Income: 306268086.84
SYP.DE cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 275365000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Operating Income: 376426000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Operating Revenue: 1604266000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 155146000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Other Current Assets: 1217584000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Other Current Borrowings: 22962000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: -240136000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Other Gand A: 136497000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Other Income Expense: 24211000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Other Intangible Assets: 173394000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: -50525000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Other Non Current Assets: 187126000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Other Non Current Liabilities: 99733000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Other Non Operating Income Expenses: -24561000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Other Properties: 1157686000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Other Short Term Investments: 144816000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Payables: 204312000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 903546000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Preferred Stock: 0.00
SYP.DE income_statement (quarterly, 2025-04-30) — Pretax Income: 396191000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Provisionand Write Offof Assets: 6021000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Purchase Of Business: 0.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Purchase Of Investment: -10369000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -55588000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Receivables: 1002195000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 273439000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 48904000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Repayment Of Debt: 0.00
SYP.DE income_statement (quarterly, 2025-04-30) — Research And Development: 553979000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Restructuring And Mergern Acquisition: 0.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 9624282000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Sale Of Business: 46274000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Sale Of Investment: 21381000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Selling And Marketing Expense: 215021000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Selling General And Administration: 351518000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Share Issued: 157261000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Special Income Charges: 48950000.00
SYP.DE cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 201723000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 9915718000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 6281052000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 5808086.84
SYP.DE income_statement (quarterly, 2025-04-30) — Tax Provision: 47181000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.12
SYP.DE balance_sheet (quarterly, 2025-04-30) — Total Assets: 23756517000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 19943399000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Total Debt: 10742251000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 9915605000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Total Expenses: 1227840000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 13840912000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 6877488000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 11434836000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: 376426000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Total Tax Payable: 119572000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Total Unusual Items: 48772000.00
SYP.DE income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: 48772000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Treasury Shares Number: 2115000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Treasury Stock: 689001000.00
SYP.DE balance_sheet (quarterly, 2025-04-30) — Working Capital: 14472953000.00
SYP.DE income_statement (quarterly, 2025-07-31) — +Operating Expense: 1193904000.00
SYP.DE income_statement (quarterly, 2025-07-31) — +Total Revenue: 1739737000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 132945000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 1392373000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 18549871000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Amortization: 28573000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Amortization Of Intangibles Income Statement: 28573000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Assets Held For Sale Current: 74317000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Basic Average Shares: 160174000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Basic EPS: 1.51
SYP.DE cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 14123433000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Capital Expenditure: -38605000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 800181000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Capital Stock: 1855000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 2526475000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 2593710000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: 4236997000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: -16499683000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: 670960000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Change In Inventory: 5698000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Change In Other Current Assets: -391735000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Change In Other Current Liabilities: -29743000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Change In Other Working Capital: -85997000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: 273913000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Change In Prepaid Assets: 260820000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Change In Receivables: 46109000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Change In Working Capital: 79065000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Changes In Account Receivables: 46109000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Changes In Cash: -11591726000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Common Stock: 1855000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 27614531000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Common Stock Issuance: 19793000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 380564000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Current Accrued Expenses: 1133196000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Current Assets: 5595628000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Current Capital Lease Obligation: 127452000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Current Debt: 22117000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 149569000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Current Deferred Liabilities: 1991429000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Current Deferred Revenue: 1991429000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 3444207000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Deferred Income Tax: -89440000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Deferred Tax: -89440000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 114469000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Depreciation Amortization Depletion Income Statement: 28573000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 114469000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Depreciation And Amortization In Income Statement: 28573000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 161682000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Diluted EPS: 1.50
SYP.DE income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: 242509000.00
SYP.DE income_statement (quarterly, 2025-07-31) — EBIT: 335812000.00
SYP.DE income_statement (quarterly, 2025-07-31) — EBITDA: 450281000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Effect Of Exchange Rate Changes: 463000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — End Cash Position: 2532170000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: 4236997000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Free Cash Flow: 632355000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Gain Loss On Investment Securities: 1200000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Gain Loss On Sale Of Business: 0.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Gain Loss On Sale Of PPE: 0.00
SYP.DE income_statement (quarterly, 2025-07-31) — Gain On Sale Of Business: -1200000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Gain On Sale Of Ppe: 0.00
SYP.DE income_statement (quarterly, 2025-07-31) — Gain On Sale Of Security: 1221000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Gains Losses Not Affecting Retained Earnings: -231895000.00
SYP.DE income_statement (quarterly, 2025-07-31) — General And Administrative Expense: 280550000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Goodwill: 26945723000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Goodwill And Other Intangible Assets: 40025635000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Gross PPE: 1393056000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Gross Profit: 1359173000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Income Tax Payable: 17063000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Interest Expense: 146502000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Interest Expense Non Operating: 146502000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Interest Income: 131417000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Interest Income Non Operating: 131417000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Interest Payable: 201103000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Inventory: 382056000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Invested Capital: 41954664000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: -16499683000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Issuance Of Capital Stock: 19793000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Issuance Of Debt: 4294876000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 672729000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Long Term Debt: 14318016000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 14990745000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Long Term Debt Issuance: 4294876000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Long Term Debt Payments: -1290000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Minority Interest: -345000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Minority Interests: 232000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Net Business Purchase And Sale: -16608793000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Net Common Stock Issuance: 19793000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Net Debt: 11813658000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Net Income: 242509000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: 242509000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: 242277000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Net Income Discontinuous Operations: 0.00
SYP.DE income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: 242509000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: 242509000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: 242277000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: 242277000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Net Interest Income: -15085000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Net Investment Purchase And Sale: 147715000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Net Issuance Payments Of Debt: 4293586000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Net Long Term Debt Issuance: 4293586000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: -15085000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Net Other Financing Charges: -76382000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Net Other Investing Changes: 0.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Net PPE: 1393056000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: -38605000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: -12411104000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Non Current Accounts Receivable: 355802000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Assets: 523923000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Liabilities: 1999091000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Revenue: 383405000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Assets: 97061000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Liabilities: 1188824000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Normalized EBITDA: 450260000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Normalized Income: 242492410.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: 670960000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Operating Gains Losses: 1200000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Operating Income: 165269000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Operating Revenue: 1739737000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 185460000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Other Current Assets: 1153172000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Other Current Borrowings: 22117000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Other Current Liabilities: 20005000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Other Equity Adjustments: -231895000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Other Gand A: 280550000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Other Income Expense: 39126000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Other Intangible Assets: 13079912000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Other Non Cash Items: 48047000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Other Non Current Assets: 336212000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Other Non Current Liabilities: 182027000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Other Non Operating Income Expenses: 39105000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Other Properties: 1393056000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Other Short Term Investments: 67235000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Payables: 150008000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 1283204000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Preferred Stock: 0.00
SYP.DE income_statement (quarterly, 2025-07-31) — Pretax Income: 189310000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Provisionand Write Offof Assets: 7619000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Purchase Of Business: -16681257000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Purchase Of Investment: -718000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -38605000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Receivables: 1392373000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 294668000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 114469000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Repayment Of Debt: -1290000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Research And Development: 625301000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 9866791000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Sale Of Business: 72464000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Sale Of Investment: 148433000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Sale Of PPE: 0.00
SYP.DE income_statement (quarterly, 2025-07-31) — Selling And Marketing Expense: 259480000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Selling General And Administration: 540030000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Share Issued: 187216000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Special Income Charges: -1200000.00
SYP.DE cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 267723000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 27614531000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: -12411104000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: 4410.00
SYP.DE income_statement (quarterly, 2025-07-31) — Tax Provision: -52967000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.21
SYP.DE balance_sheet (quarterly, 2025-07-31) — Total Assets: 48230256000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 41932547000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Total Debt: 15140314000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 27614186000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Total Expenses: 1574468000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 20616070000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 42634628000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 17171863000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: 165269000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Total Tax Payable: 17063000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Total Unusual Items: 21000.00
SYP.DE income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: 21000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Treasury Shares Number: 1756000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Treasury Stock: 572091000.00
SYP.DE balance_sheet (quarterly, 2025-07-31) — Working Capital: 2151421000.00
SYP.DE income_statement (annual, 2025-10-31) — +Operating Expense: 4515702000.00
SYP.DE income_statement (quarterly, 2025-10-31) — +Operating Expense: 1478804000.00
SYP.DE income_statement (annual, 2025-10-31) — +Total Revenue: 7054178000.00
SYP.DE income_statement (quarterly, 2025-10-31) — +Total Revenue: 2254860000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Accounts Payable: 164766000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 164766000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Accounts Receivable: 1548858000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 1548858000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Accumulated Depreciation: -965115000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -965115000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Additional Paid In Capital: 18640947000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 18640947000.00
SYP.DE income_statement (annual, 2025-10-31) — Amortization: 192525000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Amortization: 155956000.00
SYP.DE income_statement (annual, 2025-10-31) — Amortization Of Intangibles Income Statement: 192525000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Amortization Of Intangibles Income Statement: 155956000.00
SYP.DE income_statement (annual, 2025-10-31) — Basic Average Shares: 163947000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Basic Average Shares: 185779000.00
SYP.DE income_statement (annual, 2025-10-31) — Basic EPS: 8.13
SYP.DE income_statement (quarterly, 2025-10-31) — Basic EPS: 2.42
SYP.DE cash_flow (annual, 2025-10-31) — Beginning Cash Position: 3898729000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 2532170000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Buildings And Improvements: 100016000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Buildings And Improvements: 100016000.00
SYP.DE cash_flow (annual, 2025-10-31) — Capital Expenditure: -169454000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -34546000.00
SYP.DE cash_flow (annual, 2025-10-31) — Capital Expenditure Reported: 0.00
SYP.DE balance_sheet (annual, 2025-10-31) — Capital Lease Obligations: 808903000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 808903000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Capital Stock: 1860000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Capital Stock: 1860000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Cash And Cash Equivalents: 2888030000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 2888030000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 2960959000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 2960959000.00
SYP.DE cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Financing Activities: 13355757000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: -835851000.00
SYP.DE cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Investing Activities: -15881269000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: 564417000.00
SYP.DE cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Operating Activities: 1518608000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 639738000.00
SYP.DE cash_flow (annual, 2025-10-31) — Change In Inventory: -22517000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Change In Inventory: 11551000.00
SYP.DE cash_flow (annual, 2025-10-31) — Change In Other Current Assets: -481376000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Change In Other Current Assets: -53583000.00
SYP.DE cash_flow (annual, 2025-10-31) — Change In Other Current Liabilities: -113603000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Change In Other Current Liabilities: -35243000.00
SYP.DE cash_flow (annual, 2025-10-31) — Change In Other Working Capital: 241612000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Change In Other Working Capital: 401891000.00
SYP.DE cash_flow (annual, 2025-10-31) — Change In Payables And Accrued Expense: -13487000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: -44871000.00
SYP.DE cash_flow (annual, 2025-10-31) — Change In Prepaid Assets: 66918000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Change In Prepaid Assets: -53430000.00
SYP.DE cash_flow (annual, 2025-10-31) — Change In Receivables: -174140000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Change In Receivables: -146151000.00
SYP.DE cash_flow (annual, 2025-10-31) — Change In Working Capital: -496593000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Change In Working Capital: 80164000.00
SYP.DE cash_flow (annual, 2025-10-31) — Changes In Account Receivables: -174140000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Changes In Account Receivables: -146151000.00
SYP.DE cash_flow (annual, 2025-10-31) — Changes In Cash: -1006904000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Changes In Cash: 368304000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Common Stock: 1860000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Common Stock: 1860000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Common Stock Equity: 28327602000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 28327602000.00
SYP.DE cash_flow (annual, 2025-10-31) — Common Stock Issuance: 228418000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Common Stock Issuance: 90317000.00
SYP.DE cash_flow (annual, 2025-10-31) — Common Stock Payments: 0.00
SYP.DE income_statement (annual, 2025-10-31) — Cost Of Revenue: 1623549000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 654663000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Current Accrued Expenses: 1066781000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 1066781000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Current Assets: 6012102000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Current Assets: 6012102000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Current Capital Lease Obligation: 128205000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Current Capital Lease Obligation: 128205000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Current Debt: 22117000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Current Debt: 22117000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Current Debt And Capital Lease Obligation: 150322000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 150322000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Current Deferred Liabilities: 2245961000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Current Deferred Liabilities: 2245961000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Current Deferred Revenue: 2245961000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Current Deferred Revenue: 2245961000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Current Liabilities: 3722494000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 3722494000.00
SYP.DE cash_flow (annual, 2025-10-31) — Deferred Income Tax: -470693000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Deferred Income Tax: -144083000.00
SYP.DE cash_flow (annual, 2025-10-31) — Deferred Tax: -470693000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Deferred Tax: -144083000.00
SYP.DE cash_flow (annual, 2025-10-31) — Depreciation Amortization Depletion: 660430000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 449123000.00
SYP.DE income_statement (annual, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 192525000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 155956000.00
SYP.DE cash_flow (annual, 2025-10-31) — Depreciation And Amortization: 660430000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 449123000.00
SYP.DE income_statement (annual, 2025-10-31) — Depreciation And Amortization In Income Statement: 192525000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Depreciation And Amortization In Income Statement: 155956000.00
SYP.DE income_statement (annual, 2025-10-31) — Diluted Average Shares: 165656000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 187502000.00
SYP.DE income_statement (annual, 2025-10-31) — Diluted EPS: 8.04
SYP.DE income_statement (quarterly, 2025-10-31) — Diluted EPS: 2.39
SYP.DE income_statement (annual, 2025-10-31) — Diluted NI Availto Com Stockholders: 1332220000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: 448696000.00
SYP.DE income_statement (annual, 2025-10-31) — EBIT: 1839871000.00
SYP.DE income_statement (quarterly, 2025-10-31) — EBIT: 711276000.00
SYP.DE income_statement (annual, 2025-10-31) — EBITDA: 2500301000.00
SYP.DE income_statement (quarterly, 2025-10-31) — EBITDA: 1160399000.00
SYP.DE cash_flow (annual, 2025-10-31) — Effect Of Exchange Rate Changes: 1896000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Effect Of Exchange Rate Changes: -6753000.00
SYP.DE cash_flow (annual, 2025-10-31) — End Cash Position: 2893721000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — End Cash Position: 2893721000.00
SYP.DE cash_flow (annual, 2025-10-31) — Financing Cash Flow: 13355757000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: -835851000.00
SYP.DE cash_flow (annual, 2025-10-31) — Free Cash Flow: 1349154000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Free Cash Flow: 605192000.00
SYP.DE cash_flow (annual, 2025-10-31) — Gain Loss On Investment Securities: 3635000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Gain Loss On Investment Securities: 0.00
SYP.DE cash_flow (annual, 2025-10-31) — Gain Loss On Sale Of Business: -508044000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Gain Loss On Sale Of Business: -516343000.00
SYP.DE cash_flow (annual, 2025-10-31) — Gain Loss On Sale Of PPE: -51385000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Gain Loss On Sale Of PPE: 0.00
SYP.DE income_statement (annual, 2025-10-31) — Gain On Sale Of Business: 545271000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Gain On Sale Of Business: 548906000.00
SYP.DE income_statement (annual, 2025-10-31) — Gain On Sale Of Ppe: 51385000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Gain On Sale Of Ppe: 0.00
SYP.DE income_statement (annual, 2025-10-31) — Gain On Sale Of Security: 1842000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Gain On Sale Of Security: 736000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: -232414000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: -232414000.00
SYP.DE income_statement (annual, 2025-10-31) — General And Administrative Expense: 769648000.00
SYP.DE income_statement (quarterly, 2025-10-31) — General And Administrative Expense: 185515000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Goodwill: 26899215000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Goodwill: 26899215000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Goodwill And Other Intangible Assets: 39578806000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Goodwill And Other Intangible Assets: 39578806000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Gross PPE: 2363816000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Gross PPE: 2363816000.00
SYP.DE income_statement (annual, 2025-10-31) — Gross Profit: 5430629000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Gross Profit: 1600197000.00
SYP.DE cash_flow (annual, 2025-10-31) — Income Tax Paid Supplemental Data: 512705000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Income Tax Payable: 94664000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Income Tax Payable: 94664000.00
SYP.DE income_statement (annual, 2025-10-31) — Interest Expense: 446729000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Interest Expense: 194752000.00
SYP.DE income_statement (annual, 2025-10-31) — Interest Expense Non Operating: 446729000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Interest Expense Non Operating: 194752000.00
SYP.DE income_statement (annual, 2025-10-31) — Interest Income: 277684000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Interest Income: 20657000.00
SYP.DE income_statement (annual, 2025-10-31) — Interest Income Non Operating: 277684000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Interest Income Non Operating: 20657000.00
SYP.DE cash_flow (annual, 2025-10-31) — Interest Paid Supplemental Data: 353773000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Interest Payable: 49826000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Interest Payable: 49826000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Inventory: 365190000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Inventory: 365190000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Invested Capital: 41812117000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Invested Capital: 41812117000.00
SYP.DE cash_flow (annual, 2025-10-31) — Investing Cash Flow: -15881269000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: 564417000.00
SYP.DE cash_flow (annual, 2025-10-31) — Issuance Of Capital Stock: 228418000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Issuance Of Capital Stock: 90317000.00
SYP.DE cash_flow (annual, 2025-10-31) — Issuance Of Debt: 14329340000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Issuance Of Debt: 0.00
SYP.DE balance_sheet (annual, 2025-10-31) — Land And Improvements: 13888000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Land And Improvements: 13888000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Leases: 295917000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Leases: 295917000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Long Term Capital Lease Obligation: 680698000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Long Term Capital Lease Obligation: 680698000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Long Term Debt: 13462398000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Long Term Debt: 13462398000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 14143096000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 14143096000.00
SYP.DE cash_flow (annual, 2025-10-31) — Long Term Debt Issuance: 14329340000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Long Term Debt Issuance: 0.00
SYP.DE cash_flow (annual, 2025-10-31) — Long Term Debt Payments: -863637000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Long Term Debt Payments: -861058000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Machinery Furniture Equipment: 1251987000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Machinery Furniture Equipment: 1251987000.00